|
SCRN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.44579999977945E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56727999999218E-05 |
| Normal-vs-Stage2 |
6.941800E-02 |
| Normal-vs-Stage3 |
4.070600E-01 |
| Normal-vs-Stage4 |
9.501200E-01 |
| Stage1-vs-Stage2 |
7.452000E-01 |
| Stage1-vs-Stage3 |
9.274200E-02 |
| Stage1-vs-Stage4 |
1.146160E-01 |
| Stage2-vs-Stage3 |
3.301800E-01 |
| Stage2-vs-Stage4 |
2.064200E-01 |
| Stage3-vs-Stage4 |
6.307600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17960000004069E-06 |
| Normal-vs-AfricanAmerican |
4.752200E-04 |
| Normal-vs-Asian |
7.262000E-01 |
| Caucasian-vs-AfricanAmerican |
7.675800E-01 |
| Caucasian-vs-Asian |
4.366800E-01 |
| AfricanAmerican-vs-Asian |
3.853000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29520000002881E-06 |
| Normal-vs-Female |
3.594900E-04 |
| Male-vs-Female |
9.894200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.938100E-02 |
| Normal-vs-Extreme_Weight |
7.163500E-04 |
| Normal-vs-Obese |
1.018030E-03 |
| Normal-vs-Extreme_Obese |
2.133800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.741960E-01 |
| Normal_Weight-vs-Obese |
2.901000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.208000E-01 |
| Extreme_Weight-vs-Obese |
6.721400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.012000E-01 |
| Obese-vs-Extreme_Obese |
9.359200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.589940E-02 |
| Normal-vs-Age(41-60Yrs) |
2.89950000009753E-07 |
| Normal-vs-Age(61-80Yrs) |
2.753300E-04 |
| Normal-vs-Age(81-100Yrs) |
9.492400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.862200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.714800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.191600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.267900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.328000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.747190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.09540043702339E-10 |
| Normal-VS-Type2 PRCC |
9.363400E-01 |
| Normal-VS-KIRP CIMP |
1.500550E-01 |
| Normal-VS-Unclassified PRCC |
9.361600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.74530000007778E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.418000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.021200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.420200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.832800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.549600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.683800E-01 |
| Normal-vs-N1 |
4.683200E-01 |
| Normal-vs-N2 |
1.667350E-01 |
| N0-vs-N1 |
9.160600E-01 |
| N0-vs-N2 |
5.532800E-01 |
| N1-vs-N2 |
4.702000E-01 |
|
|
